Brief: Cyclerion Announces Strategic Agreement with Medsteer
05/01/2026 22:14
Jan 5 (Reuters) - Cyclerion Therapeutics Inc CYCN.O: CYCLERION THERAPEUTICS ANNOUNCES STRATEGIC AGREEMENT WITH MEDSTEER AND PROGRESS TOWARD INITIATING PHASE 2 PROOF-OF-CONCEPT STUDY FOR CYC-126 IN TREATMENT-RESISTANT DEPRESSION Source text: ID:nGNX63RCx2 Further company coverage: CYCN.O ((Reuters.Briefs@thomsonreuters.com;))